Jiangsu gdk Biotechnology Co., Ltd. (688670.SS)

CNY 14.38

(0.0%)

Total Assets Summary of Jiangsu gdk Biotechnology Co., Ltd.

  • Jiangsu gdk Biotechnology Co., Ltd.'s latest annual total assets in 2023 was 1.63 Billion CNY , down -10.68% from previous year.
  • Jiangsu gdk Biotechnology Co., Ltd.'s latest quarterly total assets in 2024 Q3 was 1.55 Billion CNY , up 1.19% from previous quarter.
  • Jiangsu gdk Biotechnology Co., Ltd. reported annual total assets of 1.82 Billion CNY in 2022, up 4.12% from previous year.
  • Jiangsu gdk Biotechnology Co., Ltd. reported annual total assets of 1.75 Billion CNY in 2021, up 125.52% from previous year.
  • Jiangsu gdk Biotechnology Co., Ltd. reported quarterly total assets of 1.58 Billion CNY for 2024 Q1, down -3.02% from previous quarter.
  • Jiangsu gdk Biotechnology Co., Ltd. reported quarterly total assets of 1.53 Billion CNY for 2024 Q2, down -2.68% from previous quarter.

Annual Total Assets Chart of Jiangsu gdk Biotechnology Co., Ltd. (2023 - 2017)

Historical Annual Total Assets of Jiangsu gdk Biotechnology Co., Ltd. (2023 - 2017)

Year Total Assets Total Assets Growth
2023 1.63 Billion CNY -10.68%
2022 1.82 Billion CNY 4.12%
2021 1.75 Billion CNY 125.52%
2020 777.97 Million CNY 95.82%
2019 397.29 Million CNY 27.59%
2018 311.38 Million CNY 4.47%
2017 298.06 Million CNY 0.0%

Peer Total Assets Comparison of Jiangsu gdk Biotechnology Co., Ltd.

Name Total Assets Total Assets Difference
Beijing Tiantan Biological Products Co., Ltd. 14.18 Billion CNY 88.5%
JiangSu WuZhong Pharmaceutical Development Co., Ltd. 4.32 Billion CNY 62.291%
Jinyu Bio-technology Co., Ltd. 6.87 Billion CNY 76.259%
Vcanbio Cell & Gene Engineering Corp., Ltd 5.41 Billion CNY 69.849%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 14.38 Billion CNY 88.657%
Zhejiang Ausun Pharmaceutical Co., Ltd. 2.95 Billion CNY 44.721%
DaShenLin Pharmaceutical Group Co., Ltd. 24.12 Billion CNY 93.236%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 15.71 Billion CNY 89.618%
GuiZhou SanLi Pharmaceutical Co.,Ltd 2.92 Billion CNY 44.132%
Pulike Biological Engineering, Inc. 3.26 Billion CNY 49.985%
Beijing Konruns Pharmaceutical Co.,Ltd. 3.78 Billion CNY 56.845%
Shanghai Hile Bio-Technology Co., Ltd. 1.65 Billion CNY 1.577%
Qingdao Vland Biotech INC. 3.03 Billion CNY 46.224%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 3.17 Billion CNY 48.601%
Aurisco Pharmaceutical Co.,Ltd. 2.57 Billion CNY 36.627%
Zhejiang East Asia Pharmaceutical Co., Ltd. 3.34 Billion CNY 51.199%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 3.06 Billion CNY 46.689%
Mabwell (Shanghai) Bioscience Co., Ltd. 4.45 Billion CNY 63.376%
Beijing Hotgen Biotech Co., Ltd. 3.56 Billion CNY 54.176%
Assure Tech (Hangzhou) Co., Ltd. 5.78 Billion CNY 71.818%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 3.54 Billion CNY 54.004%
Cabio Biotech (Wuhan) Co., Ltd. 1.61 Billion CNY -1.248%
Shanghai Shen Lian Biomedical Corporation 1.59 Billion CNY -2.359%
Nanjing Vazyme Biotech Co., Ltd. 5.74 Billion CNY 71.605%
Shandong Kexing Bioproducts Co,.Ltd 3.03 Billion CNY 46.171%
Shanghai Junshi Biosciences Co., Ltd. 11.34 Billion CNY 85.616%
Shanghai Model Organisms Center, Inc. 1.99 Billion CNY 18.329%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. 2.88 Billion CNY 43.489%
Xiamen Amoytop Biotech Co., Ltd. 2.35 Billion CNY 30.75%
Novogene Co., Ltd. 3.59 Billion CNY 54.607%
Shanghai ZJ Bio-Tech Co., Ltd. 4.07 Billion CNY 59.953%
Chengdu Olymvax Biopharmaceuticals Inc. 1.61 Billion CNY -1.178%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd 5.3 Billion CNY 69.244%
Shanghai Haohai Biological Technology Co., Ltd. 7.1 Billion CNY 77.037%
Jiangsu Bioperfectus Technologies Co., Ltd. 3.9 Billion CNY 58.233%
Jiangsu Aidea Pharmaceutical Co., Ltd. 1.74 Billion CNY 6.582%
Chengdu Easton Biopharmaceuticals Co., Ltd. 3.34 Billion CNY 51.248%
Sinocelltech Group Limited 2.71 Billion CNY 39.982%
Wuhan Keqian Biology Co.,Ltd 4.67 Billion CNY 65.071%
Shanghai Allist Pharmaceuticals Co., Ltd. 4.37 Billion CNY 62.719%
Anhui Huaheng Biotechnology Co., Ltd. 3.97 Billion CNY 58.904%
Youcare Pharmaceutical Group Co., Ltd. 5.91 Billion CNY 72.398%
Beijing Kawin Technology Share-Holding Co., Ltd. 2.44 Billion CNY 33.355%
Hangzhou Biotest Biotech Co.,Ltd. 2.57 Billion CNY 36.749%